​
​

Estrella Immunopharma Ownership 2024 | Who Owns Estrella Immunopharma Now?

OverviewFinancialsChart

Insider Ownership

71.03%

Estrella Immunopharma Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY CONCORD STREET TRUST0.00%57,95156,3693563.15%Feb 29, 2024
VANGUARD INDEX FUNDS0.00%3,6833,683-Mar 31, 2024

Estrella Immunopharma's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 57.95K shares, compromising 0.00% of its total assets.

Estrella Immunopharma Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 17, 2022Li Jianweiofficer Co-Chief Executive OfficerP-PurchaseBuy141,970$314.70K$44.68B1,253,730

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 17, 2022Li Jianweiofficer Co-Chief Executive OfficerP-PurchaseBuy141,970$314.70K$44.68B1,253,730

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 10, 2023Xu Jiandongofficer Chief Financial OfficerSell---264,388
Oct 10, 2023Liu Chengdirector, officer Chief Executive OfficerSell---297,437
Oct 10, 2023Eureka Therapeutics, Inc.10 percent owner-Sell---25,277,831
Oct 05, 2023Owl Creek Asset Management, L.P.10 percent owner-J-OtherSell255,000$10.86$2.77M-
Jul 26, 2021Jiang Taodirector-Sell---10,000
Jul 22, 2021Twigg Westondirector-Sell---10,000
Jul 22, 2021Long Jamesdirector-Sell---10,000

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 10, 2023Xu Jiandongofficer Chief Financial OfficerSell---264,388
Oct 10, 2023Roberts Marshadirector Buy----
Oct 10, 2023Xu Peidirector Buy----
Oct 10, 2023Liu Chengdirector, officer Chief Executive OfficerSell---297,437
Oct 10, 2023Wu Xuejun Janelledirector Buy----
Oct 10, 2023Wu Fandirector Buy----
Oct 10, 2023Eureka Therapeutics, Inc.10 percent owner-Sell---25,277,831
Oct 05, 2023Owl Creek Asset Management, L.P.10 percent owner-J-OtherSell255,000$10.86$2.77M-
Oct 02, 2023TradeUP Acquisition Sponsor LLC-Buy----
Oct 02, 2023Long James-Buy----
Oct 02, 2023Jiang Tao-Buy----
Oct 02, 2023Wen Luqi-Buy----
Oct 02, 2023Li Jianwei-Buy----
Oct 02, 2023Twigg Weston-Buy----
Oct 02, 2023Yang Weiguang-Buy----
Jan 09, 2023Owl Creek Asset Management, L.P.director-Buy---255,000
Mar 17, 2022Li Jianweiofficer Co-Chief Executive OfficerP-PurchaseBuy141,970$314.70K$44.68B1,253,730
Jul 26, 2021Jiang Taodirector-Sell---10,000
Jul 22, 2021Twigg Westondirector-Sell---10,000
Jul 22, 2021Long Jamesdirector-Sell---10,000

The last insider sell of Estrella Immunopharma's stock was made by Xu Jiandong on Oct 10 2023, selling - shares at - per share (valued at -). The last insider buy of ESLA was made by Li Jianwei on Mar 17 2022, buying 141,970 shares at $314.70K per share (worth $44.68B).

Estrella Immunopharma Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

ESLA Ownership FAQ